Efficacy and safety study of the antihistamine V0114CP 2.5MG in the treatment of perennial allergic rhinitis. Randomised, double blind, tree arm parallel group study including placebo and active control
Efficacy and safety study of the antihistamine V0114CP 2.5MG in the treatment of perennial allergic rhinitis. Randomised, double blind, tree arm parallel group study including placebo and active control
Efficacy and safety study of the antihistamine V0114CP 2.5MG in the treatment of perennial allergic rhinitis. Randomised, double blind, tree arm parallel group study including placebo and active control
Statut
Status :
Terminé
Type d'étude
Phase III
Age Min.
18
Ans
Age Max.
-
Genre
Tous
Aire thérapeutique :
Allergies
Maladie :
Rhinite allergique
Traitement :
L-mequitazine (Xyzall®)
Phase :
Phase III
Date de début de l'étude :
13 Février 2008
End date :
27 Août 2009
Identifiant de l'essai :
V00114 CP 302 2A
Identifiant EudraCT/CTIS :
2007-003572-19
Envoyer par email